Provexis (LON:PXS) Releases Earnings Results

Provexis (LON:PXS – Get Free Report) issued its earnings results on Thursday. The company reported GBX (0.02) EPS for the quarter, Digital Look Earnings reports. Provexis had a negative return on equity of 49.45% and a negative net margin of 69.30%.

Provexis Price Performance

LON:PXS traded up GBX 0.03 during trading hours on Friday, reaching GBX 0.97. The company had a trading volume of 223,822 shares, compared to its average volume of 1,952,980. Provexis has a 1-year low of GBX 0.55 and a 1-year high of GBX 1.55. The business’s 50 day moving average price is GBX 1.05 and its 200-day moving average price is GBX 1.07. The firm has a market cap of £22.73 million, a PE ratio of -48.45 and a beta of 0.66.

About Provexis

(Get Free Report)

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function.

Further Reading

Receive News & Ratings for Provexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provexis and related companies with MarketBeat.com's FREE daily email newsletter.